Volume 26, Number 11—November 2020
Dispatch
Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April–July 2020
Anuradha Chowdhary
, Bansidhar Tarai, Ashutosh Singh, and Amit Sharma
, Bansidhar Tarai, Ashutosh Singh, and Amit Sharma
Table 2
Drug MICs for Candida spp.in 15 coronavirus disease patients, India, April–July 2020*
| Drug | Patient no. (Candida sp.), drug MIC, μg/mL |
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 (C. auris) | 2 (C. auris) | 3 (C. auris) † | 4 (C. auris) | 5 (C. auris) | 6 (C. auris) † | 7 (C. auris) | 8 (C. auris) | 9 (C. auris) | 10 (C. auris) | 11 (C. tropicalis) | 12 (C. albicans) | 13 (C. albicans) | 14 (C. albicans) | 15 (C. krusei) | |
| FLU | 512 | 256 | 256/256 | 512 | 256 | 256/256 | 512 | 256 | 256 | 512 | 0.25 | 0.5 | 0.5 | 0.5 | 16 |
| VRC | 2 | 0.5 | 1/1 | 1 | 1 | 1/0.5 | 0.25 | 2 | 2 | 0.125 | 0.03 | 0.125 | 0.125 | 0.125 | 0.125 |
| ISA | 0.5 | 0.25 | 0.125/0.25 | 0.03 | 0.06 | 0.125/0.25 | 0.5 | 0.06 | 0.06 | 0.06 | 0.015 | 0.125 | 0.125 | 0.125 | 0.125 |
| POS | 0.25 | 0.125 | 0.125/0.125 | 0.015 | 0.06 | 0.03/0.03 | 0.125 | 0.06 | 0.03 | 0.06 | 0.015 | 0.125 | 0.25 | 0.25 | 0.25 |
| AMB | 0.5 | 0.5 | 0.125/0.25 | 0.5 | 2 | 1/1 | 2 | 4 | 1 | 4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| CAS | 2 | 2 | 2/4 | 1 | 0.5 | 0.5/0.25 | 0.25 | 1 | 0.5 | 1 | 1 | 0.125 | 0.125 | 0.125 | 10.5 |
| AFG | 0.125 | 0.25 | 0.25/0.5 | 0.125 | 0.25 | 0.125/0.25 | 0.5 | 0.125 | 0.125 | 0.25 | 0.06 | 0.06 | 0.03 | 0.03 | 0.125 |
| MFG | 0.06 | 0.25 | 0.5/0.5 | 0.06 | 0.03 | 0.25/0.125 | 0.125 | 0.25 | 0.125 | 0.125 | 0.06 | 0.06 | 0.06 | 0.06 | 0.125 |
| 5-FC | 32 | 8 | 8/16 | 1 | 1 | 64/64 | 64 | 64 | 64 | 64 | 0.125 | 0.5 | 1 | 1 | 16 |
*AFG, anidulafungin; AMB, amphotericin B; CAS, caspofungin; FLC, fluconazole; ISA, isavuconazole; MFG, micafungin; POS, posaconazole; VRC, voriconazole; 5-FC, 5-flucytosine. †C. auris isolated from blood and urine.
Page created: August 18, 2020
Page updated: October 19, 2020
Page reviewed: October 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.